Leadership is not about having all the answers. Experienced leadership is knowing which questions to ask.
The critical question in early clinical development is does it work? Once this hurdle is cleared the question evolves into does it work enough?
Reflected and informed design of the clinical development strategy and of each individual clinical study is critical to reveal the full potential of a candidate therapeutic.
Managing clinical safety during the bio-pharmaceutical development is a distinct discipline. Methods and practices differ from those applied characterizing efficacy.
Tailored monitoring and balanced interpretation of accruing data are essential over the entire life-cycle of safety management.
To achieve a smooth review process and ultimately regulatory approval rests on a nuanced appreciation of how best to present information in the clinical dossier in order to build a coherent and compelling case. It requires the unique combination of a sound command of the English language, state-of-the-art medical and clinical research expertise, and appreciation of regulatory thinking.